tiprankstipranks
Trending News
More News >
Krystal Biotech (KRYS)
NASDAQ:KRYS
US Market

Krystal Biotech (KRYS) Ratios

Compare
637 Followers

Krystal Biotech Ratios

KRYS's free cash flow for Q4 2025 was $0.90. For the 2025 fiscal year, KRYS's free cash flow was decreased by $ and operating cash flow was $0.35. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
9.95 9.95 7.28 17.76 13.30
Quick Ratio
9.56 9.56 7.02 17.55 13.30
Cash Ratio
4.82 4.82 3.38 10.83 5.61
Solvency Ratio
1.85 1.85 0.88 0.42 -3.77
Operating Cash Flow Ratio
1.95 1.95 1.21 -2.68 -3.49
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 910.37M$ 910.37M$ 632.59M$ 548.20M$ 347.56M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 0.02
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 0.01 0.02
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 0.01 0.02
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.09 1.09 1.12 1.05 1.07
Debt Service Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.32 0.32 0.25 0.30 0.35
Net Debt to EBITDA
-2.90 -2.90 -3.07 3.84 1.31
Profitability Margins
Gross Profit Margin
92.61%92.61%93.09%93.90%0.00%
EBIT Margin
41.45%41.45%35.52%-191.77%0.00%
EBITDA Margin
43.13%43.13%37.83%-180.11%0.00%
Operating Profit Margin
41.45%41.45%22.61%-216.43%0.00%
Pretax Profit Margin
48.69%48.69%32.82%25.44%0.00%
Net Profit Margin
52.64%52.64%30.69%21.56%0.00%
Continuous Operations Profit Margin
52.64%52.64%30.69%21.56%0.00%
Net Income Per EBT
108.11%108.11%93.50%84.76%100.00%
EBT Per EBIT
117.47%117.47%145.15%-11.75%96.40%
Return on Assets (ROA)
15.36%15.36%8.44%1.34%-25.06%
Return on Equity (ROE)
18.69%16.80%9.42%1.40%-26.80%
Return on Capital Employed (ROCE)
13.10%13.10%6.89%-13.97%-27.42%
Return on Invested Capital (ROIC)
13.09%13.09%6.43%-11.82%-27.34%
Return on Tangible Assets
15.36%15.36%8.44%1.34%-25.06%
Earnings Yield
2.74%2.87%1.99%0.32%-6.93%
Efficiency Ratios
Receivables Turnover
3.05 3.05 2.77 1.21 0.00
Payables Turnover
8.89 8.89 4.02 1.67 0.00
Inventory Turnover
0.71 0.71 0.76 0.44 0.00
Fixed Asset Turnover
2.46 2.46 1.80 0.30 0.00
Asset Turnover
0.29 0.29 0.28 0.06 0.00
Working Capital Turnover Ratio
0.44 0.50 0.49 0.11 0.00
Cash Conversion Cycle
591.89 591.89 523.20 908.56 0.00
Days of Sales Outstanding
119.52 119.52 131.60 302.66 0.00
Days of Inventory Outstanding
513.45 513.45 482.30 824.02 0.00
Days of Payables Outstanding
41.08 41.08 90.70 218.13 0.00
Operating Cycle
632.97 632.97 613.90 1.13K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
6.94 6.94 4.32 -3.27 -3.95
Free Cash Flow Per Share
6.53 6.53 4.17 -3.70 -6.02
CapEx Per Share
0.41 0.41 0.15 0.43 2.08
Free Cash Flow to Operating Cash Flow
0.94 0.94 0.97 1.13 1.53
Dividend Paid and CapEx Coverage Ratio
16.81 16.81 29.12 -7.53 -1.90
Capital Expenditure Coverage Ratio
16.81 16.81 29.12 -7.53 -1.90
Operating Cash Flow Coverage Ratio
21.51 21.51 17.00 -10.97 -11.26
Operating Cash Flow to Sales Ratio
0.52 0.52 0.42 -1.75 0.00
Free Cash Flow Yield
2.50%2.65%2.66%-2.99%-7.60%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
35.44 34.84 50.24 308.15 -14.43
Price-to-Sales (P/S) Ratio
18.84 18.34 15.42 66.45 0.00
Price-to-Book (P/B) Ratio
5.95 5.85 4.73 4.33 3.87
Price-to-Free Cash Flow (P/FCF) Ratio
38.81 37.77 37.58 -33.49 -13.15
Price-to-Operating Cash Flow Ratio
36.14 35.53 36.29 -37.93 -20.08
Price-to-Earnings Growth (PEG) Ratio
12.85 0.27 0.07 -2.87 -0.19
Price-to-Fair Value
5.95 5.85 4.73 4.33 3.87
Enterprise Value Multiple
40.78 39.61 37.68 -33.06 -15.98
Enterprise Value
7.05B 6.65B 4.14B 3.02B 1.87B
EV to EBITDA
42.03 39.61 37.68 -33.06 -15.98
EV to Sales
18.13 17.09 14.26 59.54 0.00
EV to Free Cash Flow
37.34 35.20 34.75 -30.00 -12.16
EV to Operating Cash Flow
35.12 33.10 33.56 -33.99 -18.56
Tangible Book Value Per Share
42.14 42.14 33.10 28.68 20.49
Shareholders’ Equity Per Share
42.14 42.14 33.10 28.68 20.49
Tax and Other Ratios
Effective Tax Rate
-0.08 -0.08 0.06 0.15 0.00
Revenue Per Share
13.44 13.44 10.16 1.87 0.00
Net Income Per Share
7.08 7.08 3.12 0.40 -5.49
Tax Burden
1.08 1.08 0.94 0.85 1.00
Interest Burden
1.17 1.17 0.92 -0.13 1.16
Research & Development to Revenue
0.15 0.15 0.18 0.92 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.07 0.14 0.17 0.79 0.00
Income Quality
0.98 0.98 1.38 -8.12 0.72
Currency in USD